for Health Care Providers
Treatment Complications
Back to: Image Library | Treatment Complications
Drug rash: nonnucleoside reverse transcriptase inhibitor associated
Credits
Pediatric AIDS Pictoral Atlas, Baylor International Pediatric AIDS Initiative
Description
Nonnucleoside reverse transcriptase inhibitor-associated rash on a 12-year-old girl who had begun antiretroviral therapy with efavirenz (Sustiva) 1 week previously. Rash is one of the most common side effects observed with nonnucleoside reverse transcriptase inhibitors.